GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we handle diabetes mellitus . These new medications work by stimulating the body’s natural GLP-1 hormone https://social-galaxy.com/story7303847/glp-1-a-revolutionary-approach-in-blood-sugar-management